Abbasi B, Kimiagar M, Sadeghniiat K, et al
Several research priorities emerge from our study
It should be used with caution in neonates, premature infants, children, and adolescents (aged below 18 years) and is advised to be used with caution in elderly patients (aged 70 years and above) after consulting the doctor
Whilst GLP-1 receptor agonists enhance the body's natural insulin response and reduce appetite, SGLT2 inhibitors provide glucose elimination through the kidneys
With our expert team and access to the latest advancements in weight loss medication, we ensure you have a positive, successful experience tailored to your needs
Furthermore, many more pharmacological classes have been developed over the last years that need acknowledgement